NuCana is trading 5.53% higher in pre-market at $1.04; no fresh company-specific announcement explaining the October 26 move was identified. - The supplied price context compares this with the October 23 close of $0.99. - NuCana’s European patent news dates to September 30 and is not a new catalyst; prior coverage also described the earlier gain as lacking a verified company-specific reason. - Major indices are up modestly, but none exceeds the stated 0.5% threshold for attributing the move to broader market sentiment.